Ownership history in Man Group plc Β· 21 quarters on record
This page tracks every 13F SEC filing in which Man Group plc reported a position in REPLIGEN CORP (RGEN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π Man Group plc underperformed the S&P 500 by β6.9% annually on this RGEN position. Timing score: 47% (9/19 decisions correct). Average cost basis: $141.07. Maximum drawdown during holding period: β57.0%.
β Significantly underperformed the S&P 500 by 6.9% ann.
19 quarters analyzed
β‘οΈ Neutral timing β roughly coin-flip accuracy on add/trim calls.
9 of 19 add/trim decisions correct
Best entry: $92.50 (2019 Q4) Β· Worst: $264.84 (2021 Q4)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
9 adds Β· 12 trims. Bought during 3 of 8 down-price quarters. π Predominantly trimming β distribution phase.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.02% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size